{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T05:16:50Z","timestamp":1793078210926,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"7908","license":[{"start":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T00:00:00Z","timestamp":1647820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T00:00:00Z","timestamp":1647820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2022,5,5]]},"DOI":"10.1038\/s41586-022-04630-3","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T11:03:30Z","timestamp":1647860610000},"page":"146-151","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":187,"title":["Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19"],"prefix":"10.1038","volume":"605","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0727-8289","authenticated-orcid":false,"given":"Lok-Yin Roy","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6518-6369","authenticated-orcid":false,"given":"Kevin","family":"Wilhelmsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel E.","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5189-4943","authenticated-orcid":false,"given":"Nicholas J.","family":"Schnicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Thurman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7544-5109","authenticated-orcid":false,"given":"Alejandro A.","family":"Pezzulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Szachowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9062-3735","authenticated-orcid":false,"given":"Pengfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruangang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Klumpp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Aswad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Rebo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8062-6529","authenticated-orcid":false,"given":"Shuh","family":"Narumiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2549-6826","authenticated-orcid":false,"given":"Sonia","family":"Zuniga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Sola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Enjuanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1552-3253","authenticated-orcid":false,"given":"David K.","family":"Meyerholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Fortney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4067-577X","authenticated-orcid":false,"suffix":"Jr","given":"Paul B.","family":"McCray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4213-2354","authenticated-orcid":false,"given":"Stanley","family":"Perlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,21]]},"reference":[{"key":"4630_CR1","doi-asserted-by":"publisher","first-page":"6204","DOI":"10.1172\/JCI144115","volume":"130","author":"R Channappanavar","year":"2020","unstructured":"Channappanavar, R. & Perlman, S. Age-related susceptibility to coronavirus infections: role of impaired and dysregulated host immunity. J. Clin. Invest. 130, 6204\u20136213 (2020).","journal-title":"J. Clin. Invest."},{"key":"4630_CR2","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.chom.2021.02.020","volume":"29","author":"JA Plante","year":"2021","unstructured":"Plante, J. A. et al. The variant gambit: COVID-19\u2019s next move. Cell Host Microbe 29, 508\u2013515 (2021).","journal-title":"Cell Host Microbe"},{"key":"4630_CR3","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1084\/jem.20150632","volume":"212","author":"R Vijay","year":"2015","unstructured":"Vijay, R. et al. Critical role of phospholipase A2 group IID in age-related susceptibility to severe acute respiratory syndrome-CoV infection. J. Exp. Med. 212, 1851\u20131868 (2015).","journal-title":"J. Exp. Med."},{"key":"4630_CR4","doi-asserted-by":"publisher","first-page":"4921","DOI":"10.1172\/JCI59777","volume":"121","author":"J Zhao","year":"2011","unstructured":"Zhao, J., Zhao, J., Legge, K. & Perlman, S. Age-related increases in PGD2 expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice. J. Clin. Invest. 121, 4921\u20134930 (2011).","journal-title":"J. Clin. Invest."},{"key":"4630_CR5","first-page":"e00127","volume":"94","author":"Y Wan","year":"2020","unstructured":"Wan, Y., Shang, J., Graham, R., Baric, R. S. & Li, F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J. Virol. 94, e00127\u201320 (2020).","journal-title":"J. Virol."},{"key":"4630_CR6","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/s41586-020-2312-y","volume":"583","author":"L Bao","year":"2020","unstructured":"Bao, L. et al. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature 583, 830\u2013833 (2020).","journal-title":"Nature"},{"key":"4630_CR7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.cell.2020.05.027","volume":"182","author":"RD Jiang","year":"2020","unstructured":"Jiang, R. D. et al. Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2. Cell 182, 50\u201358 (2020).","journal-title":"Cell"},{"key":"4630_CR8","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/s41590-020-0778-2","volume":"21","author":"ES Winkler","year":"2020","unstructured":"Winkler, E. S. et al. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nat. Immunol. 21, 1327\u20131335 (2020).","journal-title":"Nat. Immunol."},{"key":"4630_CR9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-020-2943-z","volume":"589","author":"J Zheng","year":"2021","unstructured":"Zheng, J. et al. COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice. Nature 589, 603\u2013607 (2021).","journal-title":"Nature"},{"key":"4630_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.chom.2020.05.020","volume":"28","author":"SH Sun","year":"2020","unstructured":"Sun, S. H. et al. A mouse model of SARS-CoV-2 infection and pathogenesis. Cell Host Microbe 28, 124\u2013133 (2020).","journal-title":"Cell Host Microbe"},{"key":"4630_CR11","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.cell.2020.06.011","volume":"182","author":"AO Hassan","year":"2020","unstructured":"Hassan, A. O. et al. A SARS-CoV-2 infection model in mice demonstrates protection by neutralizing antibodies. Cell 182, 744\u2013753 (2020).","journal-title":"Cell"},{"key":"4630_CR12","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.cell.2020.06.010","volume":"182","author":"J Sun","year":"2020","unstructured":"Sun, J. et al. Generation of a broadly useful model for COVID-19 pathogenesis, vaccination, and treatment. Cell 182, 734\u2013743 (2020).","journal-title":"Cell"},{"key":"4630_CR13","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41586-020-2708-8","volume":"586","author":"KH Dinnon III","year":"2020","unstructured":"Dinnon, K. H. III et al. A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures. Nature 586, 560\u2013566 (2020).","journal-title":"Nature"},{"key":"4630_CR14","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1126\/science.abc4730","volume":"369","author":"H Gu","year":"2020","unstructured":"Gu, H. et al. Adaptation of SARS-CoV-2 in BALB\/c mice for testing vaccine efficacy. Science 369, 1603\u20131607 (2020).","journal-title":"Science"},{"key":"4630_CR15","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.cell.2020.09.050","volume":"183","author":"SR Leist","year":"2020","unstructured":"Leist, S. R. et al. A mouse-adapted SARS-CoV-2 induces acute lung injury and mortality in standard laboratory mice. Cell 183, 1070\u20131085 (2020).","journal-title":"Cell"},{"key":"4630_CR16","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1038\/nm1143","volume":"10","author":"JS Peiris","year":"2004","unstructured":"Peiris, J. S., Guan, Y. & Yuen, K. Y. Severe acute respiratory syndrome. Nat. Med. 10, S88\u2013S97 (2004).","journal-title":"Nat. Med."},{"key":"4630_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-1-0716-0211-9_5","volume":"2099","author":"AR Fehr","year":"2020","unstructured":"Fehr, A. R. Bacterial artificial chromosome-based lambda red recombination with the I-SceI homing endonuclease for genetic alteration of MERS-CoV. Methods Mol. Biol. 2099, 53\u201368 (2020).","journal-title":"Methods Mol. Biol."},{"key":"4630_CR18","doi-asserted-by":"publisher","first-page":"103381","DOI":"10.1016\/j.ebiom.2021.103381","volume":"67","author":"K Huang","year":"2021","unstructured":"Huang, K. et al. Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice. EBioMedicine 67, 103381 (2021).","journal-title":"EBioMedicine"},{"key":"4630_CR19","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1007\/s13238-020-00767-x","volume":"11","author":"J Wang","year":"2020","unstructured":"Wang, J. et al. Mouse-adapted SARS-CoV-2 replicates efficiently in the upper and lower respiratory tract of BALB\/c and C57BL\/6J mice. Protein Cell 11, 776\u2013782 (2020).","journal-title":"Protein Cell"},{"key":"4630_CR20","first-page":"e02477","volume":"95","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. SARS-CoV-2 rapidly adapts in aged BALB\/c mice and induces typical pneumonia. J. Virol. 95, e02477\u201320 (2021).","journal-title":"J. Virol."},{"key":"4630_CR21","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.cell.2020.08.012","volume":"182","author":"TN Starr","year":"2020","unstructured":"Starr, T. N. et al. Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding. Cell 182, 1295\u20131310 (2020).","journal-title":"Cell"},{"key":"4630_CR22","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1016\/j.cell.2021.02.042","volume":"184","author":"Q Li","year":"2021","unstructured":"Li, Q. et al. SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape. Cell 184, 2362\u20132371 (2021).","journal-title":"Cell"},{"key":"4630_CR23","doi-asserted-by":"crossref","unstructured":"Sun, H. et al. Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2. Nat. Commun. 12, 5654 (2021).","DOI":"10.1038\/s41467-021-25903-x"},{"key":"4630_CR24","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1371\/journal.ppat.0030005","volume":"3","author":"A Roberts","year":"2007","unstructured":"Roberts, A. et al. A mouse-adapted SARS-coronavirus causes disease and mortality in BALB\/c mice. PLoS Pathog. 3, e5 (2007).","journal-title":"PLoS Pathog."},{"key":"4630_CR25","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2015432","volume":"383","author":"M Ackermann","year":"2020","unstructured":"Ackermann, M. et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N. Engl. J. Med. 383, 120\u2013128 (2020).","journal-title":"N. Engl. J. Med."},{"key":"4630_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41590-020-00840-x","volume":"22","author":"IE Galani","year":"2021","unstructured":"Galani, I. E. et al. Untuned antiviral immunity in COVID-19 revealed by temporal type I\/III interferon patterns and flu comparison. Nat. Immunol. 22, 32\u201340 (2021).","journal-title":"Nat. Immunol."},{"key":"4630_CR27","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41586-020-2355-0","volume":"583","author":"X Zhang","year":"2020","unstructured":"Zhang, X. et al. Viral and host factors related to the clinical outcome of COVID-19. Nature 583, 437\u2013440 (2020).","journal-title":"Nature"},{"key":"4630_CR28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ejphar.2007.01.003","volume":"560","author":"Y Hirano","year":"2007","unstructured":"Hirano, Y. et al. Synergistic effect of PGD2 via prostanoid DP receptor on TNF-\u03b1-induced production of MCP-1 and IL-8 in human monocytic THP-1 cells. Eur. J. Pharmacol. 560, 81\u201388 (2007).","journal-title":"Eur. J. Pharmacol."},{"key":"4630_CR29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ejphar.2011.05.003","volume":"666","author":"Y Hirano","year":"2011","unstructured":"Hirano, Y. et al. Prostanoid DP receptor antagonists suppress symptomatic asthma-like manifestation by distinct actions from a glucocorticoid in rats. Eur. J. Pharmacol. 666, 233\u2013241 (2011).","journal-title":"Eur. J. Pharmacol."},{"key":"4630_CR30","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/s41385-021-00405-7","volume":"14","author":"MA Ullah","year":"2021","unstructured":"Ullah, M. A., Rittchen, S., Li, J., Hasnain, S. Z. & Phipps, S. DP1 prostanoid receptor activation increases the severity of an acute lower respiratory viral infection in mice via TNF-\u03b1-induced immunopathology. Mucosal Immunol. 14, 963\u2013972 (2021).","journal-title":"Mucosal Immunol."},{"key":"4630_CR31","doi-asserted-by":"publisher","first-page":"15588","DOI":"10.1074\/jbc.M116.734624","volume":"291","author":"Y Miki","year":"2016","unstructured":"Miki, Y. et al. Dual roles of group IID phospholipase A2 in inflammation and cancer. J. Biol. Chem. 291, 15588\u201315601 (2016).","journal-title":"J. Biol. Chem."},{"key":"4630_CR32","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1084\/jem.20121887","volume":"210","author":"Y Miki","year":"2013","unstructured":"Miki, Y. et al. Lymphoid tissue phospholipase A2 group IID resolves contact hypersensitivity by driving antiinflammatory lipid mediators. J. Exp. Med. 210, 1217\u20131234 (2013).","journal-title":"J. Exp. Med."},{"key":"4630_CR33","doi-asserted-by":"publisher","first-page":"4708","DOI":"10.1021\/jm800422v","volume":"51","author":"RC Oslund","year":"2008","unstructured":"Oslund, R. C., Cermak, N. & Gelb, M. H. Highly specific and broadly potent inhibitors of mammalian secreted phospholipases A2. J. Med. Chem. 51, 4708\u20134714 (2008).","journal-title":"J. Med. Chem."},{"key":"4630_CR34","doi-asserted-by":"publisher","first-page":"e498","DOI":"10.1016\/S2665-9913(21)00104-1","volume":"3","author":"TM Drake","year":"2021","unstructured":"Drake, T. M. et al. Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study. Lancet Rheumatol. 3, e498\u2013e506 (2021).","journal-title":"Lancet Rheumatol."},{"key":"4630_CR35","doi-asserted-by":"publisher","unstructured":"RECOVERY Collaborative Group. Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet https:\/\/doi.org\/10.1016\/S0140-6736(21)01825-0 (2021).","DOI":"10.1016\/S0140-6736(21)01825-0"},{"key":"4630_CR36","doi-asserted-by":"publisher","first-page":"e465","DOI":"10.1016\/S2665-9913(21)00144-2","volume":"3","author":"K Kragholm","year":"2021","unstructured":"Kragholm, K., Torp-Pedersen, C. & Fosbol, E. Non-steroidal anti-inflammatory drug use in COVID-19. Lancet Rheumatol. 3, e465\u2013e466 (2021).","journal-title":"Lancet Rheumatol."},{"key":"4630_CR37","doi-asserted-by":"publisher","unstructured":"Santoro, F. et al. Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry. Heart https:\/\/doi.org\/10.1136\/heartjnl-2021-319552 (2021).","DOI":"10.1136\/heartjnl-2021-319552"},{"key":"4630_CR38","doi-asserted-by":"publisher","unstructured":"Voruganti, D., Bassareo, P. P., Calcaterra, G. & Mehta, J. L. Does aspirin save lives in patients with COVID-19? Heart https:\/\/doi.org\/10.1136\/heartjnl-2021-320255 (2021).","DOI":"10.1136\/heartjnl-2021-320255"},{"key":"4630_CR39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ejphar.2015.08.003","volume":"765","author":"G Takahashi","year":"2015","unstructured":"Takahashi, G. et al. Effect of the potent and selective DP1 receptor antagonist, asapiprant (S-555739), in animal models of allergic rhinitis and allergic asthma. Eur. J. Pharmacol. 765, 15\u201323 (2015).","journal-title":"Eur. J. Pharmacol."},{"key":"4630_CR40","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1164\/rccm.202001-0134OC","volume":"202","author":"H Furusawa","year":"2020","unstructured":"Furusawa, H. et al. Chronic hypersensitivity pneumonitis, an interstitial lung disease with distinct molecular signatures. Am. J. Respir. Crit. Care Med. 202, 1430\u20131444 (2020).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"4630_CR41","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1089\/bio.2015.29031.hmm","volume":"13","author":"LJ Carithers","year":"2015","unstructured":"Carithers, L. J. & Moore, H. M. The Genotype-Tissue Expression (GTEx) Project. Biopreserv. Biobank. 13, 307\u2013308 (2015).","journal-title":"Biopreserv. Biobank."},{"key":"4630_CR42","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/infdis\/jiaa753","volume":"223","author":"J Zheng","year":"2021","unstructured":"Zheng, J. et al. Severe acute respiratory syndrome coronavirus 2-induced immune activation and death of monocyte-derived human macrophages and dendritic cells. J. Infect. Dis. 223, 785\u2013795 (2021).","journal-title":"J. Infect. Dis."},{"key":"4630_CR43","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/13543784.2019.1555237","volume":"28","author":"G Marone","year":"2019","unstructured":"Marone, G. et al. Prostaglandin D2 receptor antagonists in allergic disorders: safety, efficacy, and future perspectives. Expert Opin. Investig. Drugs 28, 73\u201384 (2019).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"4630_CR44","doi-asserted-by":"publisher","first-page":"e00650","DOI":"10.1128\/mBio.00650-13","volume":"4","author":"F Almazan","year":"2013","unstructured":"Almazan, F. et al. Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate. MBio 4, e00650\u201313 (2013).","journal-title":"MBio"},{"key":"4630_CR45","doi-asserted-by":"publisher","first-page":"e8729","DOI":"10.1371\/journal.pone.0008729","volume":"5","author":"T Yoshikawa","year":"2010","unstructured":"Yoshikawa, T. et al. Dynamic innate immune responses of human bronchial epithelial cells to severe acute respiratory syndrome-associated coronavirus infection. PLoS ONE 5e8729 (2010).","journal-title":"PLoS ONE"},{"key":"4630_CR46","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/s41374-018-0057-0","volume":"98","author":"DK Meyerholz","year":"2018","unstructured":"Meyerholz, D. K. & Beck, A. P. Principles and approaches for reproducible scoring of tissue stains in research. Lab. Invest. 98, 844\u2013855 (2018).","journal-title":"Lab. Invest."},{"key":"4630_CR47","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/infdis\/jiv499","volume":"213","author":"K Li","year":"2016","unstructured":"Li, K. et al. Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4. J. Infect. Dis. 213, 712\u2013722 (2016).","journal-title":"J. Infect. Dis."},{"key":"4630_CR48","doi-asserted-by":"publisher","first-page":"e01456","DOI":"10.7554\/eLife.01456","volume":"2","author":"A Morin","year":"2013","unstructured":"Morin, A. et al. Collaboration gets the most out of software. Elife 2, e01456 (2013).","journal-title":"Elife"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-04630-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-04630-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-04630-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T15:08:27Z","timestamp":1660921707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-04630-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,21]]},"references-count":48,"journal-issue":{"issue":"7908","published-print":{"date-parts":[[2022,5,5]]}},"alternative-id":["4630"],"URL":"https:\/\/doi.org\/10.1038\/s41586-022-04630-3","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,21]]},"assertion":[{"value":"17 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.W., K.K., F.A., J.R. and K.F. are employees of BIOAGE Labs. All other authors have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}